0RJT Stock Chart & Stats
€56.49
€2.55(3.82%)
At close: 4:00 PM EDT
€56.49
€2.55(3.82%)
Day’s Range― - ―
52-Week Range€30.20 - €90.00
Previous CloseN/A
Volume1.09K
Average Volume (3M)2.04K
Market Cap
€1.51B
Enterprise Value€1.61K
Total Cash (Recent Filing)€118.90M
Total Debt (Recent Filing)€354.70M
Price to Earnings (P/E)―
Beta1.39
Next Earnings
Oct 29, 2026EPS Estimate
0.07Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-2.09
Shares Outstanding20,578,390
10 Day Avg. Volume2,978
30 Day Avg. Volume2,039
Financial Highlights & Ratios
PEG Ratio1.98
Price to Book (P/B)2.85
Price to Sales (P/S)0.45
P/FCF Ratio-23.25
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€96.00Price Target Upside69.94% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering8
EPS Forecast (FY)-0.26
Revenue Forecast (FY)€3.44B
Bulls Say, Bears Say
Bulls Say
Strong Revenue GrowthRapid revenue expansion demonstrates growing customer demand and increasing scale across Redcare Pharmacy’s online pharmacy and health products model. A larger revenue base can improve purchasing leverage, fulfillment efficiency, and the potential to spread operating costs over more orders.
Improving Operating PerformanceThe improvement in EBITDA margin and narrower EBIT losses indicate that operating leverage is beginning to emerge as the business scales. Continued progress could move the company closer to sustainable profitability, provided growth does not require disproportionate reinvestment or spending.
Very Low Latest DebtThe latest balance-sheet snapshot shows limited debt burden relative to the company’s asset and equity base, reducing interest and refinancing pressure if the improvement is sustainable. This gives Redcare greater flexibility to support operations and growth while profitability develops.
Bears Say
Weak And Volatile Cash GenerationRecent negative operating and free cash flow shows that reported growth is not yet converting reliably into cash. Continued cash outflows can reduce financial flexibility and may require tighter working-capital management or additional funding until cash conversion becomes consistently positive.
Persistent Net LossesDespite strong top-line growth and improving operating margins, Redcare has not yet achieved consistent bottom-line profitability. Persistent net losses limit internally generated capital, make earnings less resilient, and leave the investment case dependent on further execution and margin improvement.
Negative Returns On EquityNegative ROE indicates that the company is currently destroying rather than generating accounting returns on shareholder capital. If losses continue, equity can come under pressure over time and the company may struggle to demonstrate that its expanding revenue base creates adequate long-term shareholder returns.
0RJT FAQ
What was Redcare Pharmacy’s price range in the past 12 months?
Redcare Pharmacy lowest share price was €30.20 and its highest was €90.00 in the past 12 months.
What is Redcare Pharmacy’s market cap?
Redcare Pharmacy’s market cap is €1.51B.
When is Redcare Pharmacy’s upcoming earnings report date?
Redcare Pharmacy’s upcoming earnings report date is Oct 29, 2026 which is in 27 days.
How were Redcare Pharmacy’s earnings last quarter?
Redcare Pharmacy released its earnings results on Jul 29, 2026. The company reported €0.229 earnings per share for the quarter, beating the consensus estimate of -€0.27 by €0.499.
Is Redcare Pharmacy overvalued?
According to Wall Street analysts Redcare Pharmacy’s price is currently Undervalued.
Does Redcare Pharmacy pay dividends?
Redcare Pharmacy does not currently pay dividends.
What is Redcare Pharmacy’s EPS estimate?
Redcare Pharmacy’s EPS estimate is 0.07.
How many shares outstanding does Redcare Pharmacy have?
Redcare Pharmacy has 20,578,390 shares outstanding.
What happened to Redcare Pharmacy’s price movement after its last earnings report?
Redcare Pharmacy reported an EPS of €0.229 in its last earnings report, beating expectations of -€0.27. Following the earnings report the stock price went up 0.219%.
Which hedge fund is a major shareholder of Redcare Pharmacy?
Currently, no hedge funds are holding shares in GB:0RJT
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Redcare Pharmacy Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
€96.00 (69.94% Upside)
€96.00 (69.94% Upside)
Insider Transactions
Sold Shares
Worth €252.6K over
the Last 3 Months
the Last 3 Months
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
-8.49%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
-7.04%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Redcare Pharmacy
Redcare Pharmacy N.V. manages and runs a network of digital pharmacies across Germany, Austria, Switzerland, France, Belgium, Italy, and the Netherlands. The company offers a comprehensive selection of healthcare products, including prescription medications, over-the-counter drugs, pharmacy-related beauty and personal care items, and nutritional supplements. Established in 2001, the firm, initially known as Shop Apotheke Europe N.V., officially rebranded to Redcare Pharmacy N.V. in June 2023. Its operational headquarters are situated in Sevenum, the Netherlands.
0RJT Stock 12 Month Forecast
Average Price Target
€96.00
▲(69.94% Upside)